14.0 
CONSENT PROCEDURES 
All patients will be required to sign a statement of informed consent which must 
conform to IRB guidelines. This is included as appendix A. This research study has 
been reviewed by the IRB of Memorial Sloan-Kettering Cancer Center as well as the 
NIH Recombinant DNA Committee. The investigator will report to the IRB and the 
RAC changes in the research protocol and all unanticipated problems involving risks to 
human subjects or others, and no changes will be made in the research activity without 
IRB approval. 
[ 904 ] 
Recombinant DNA Research, Volume 15 
